Easy Access and Express Report Delivery Service
Phages, formally known as bacteriophages, are viruses that solely kill and selectively target bacteria. They are the most common biological entities in nature, and have been shown to effectively fight and destroy multi-drug resistant bacteria. Namely, when all antibiotics fail, phages still succeed in killing the bacteria and may save a life from an infection. phage has many potential applications in human medicine as well as dentistry, veterinary science, and agriculture. Highlights The global Phage Therapy market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029. The major players in global Phage Therapy market include NPO Microgen, Proteon Pharmaceuticals, Phagelux, etc. The top 3 players occupy about 25% shares of the global market. North America and Europe are main markets, they occupy about 60% of the global market. DsDNA Bacteriophage is the main type, with a share over 90%. Animal Health is the main application, which holds a share about 55%. Report Scope This report aims to provide a comprehensive presentation of the global market for Phage Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Phage Therapy. The Phage Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Phage Therapy market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments. The report will help the Phage Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions. Key Companies & Market Share Insights In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include: NPO Microgen Proteon Pharmaceuticals Phagelux Intralytix Micreos Eliava BioPreparations Locus Biosciences,Inc Pharmex Group,LLC Pherecydes Pharma APS Biocontrol Ltd. (APS) Qingdao Phagepharm Bio-tech Fixed-Phage Limited Zeptometrix Phage International, Inc. MicroMir iNtODEWORLD, Inc. NEXTBIOTICS Armata Pharmaceuticals, Inc. Innophage Adaptive Phage Therapeutics TechnoPhage Product Type Insights Global markets are presented by Phage Therapy type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Phage Therapy are procured by the companies. This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029). Phage Therapy segment by Type DsDNA Bacteriophage SsDNA Bacteriophage SsRNA Bacteriophage Others Application Insights This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029). This report also outlines the market trends of each segment and consumer behaviors impacting the Phage Therapy market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Phage Therapy market. Phage Therapy Segment by Application Animal Health Aquaculture Agriculture Food Industry Human Health Others Regional Outlook This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029. The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Phage Therapy market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come. Reasons to Buy This Report This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Phage Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market. This report will help stakeholders to understand the global industry status and trends of Phage Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition. This report stays updated with novel technology integration, features, and the latest developments in the market This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Phage Therapy industry. This report helps stakeholders to gain insights into which regions to target globally This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Phage Therapy. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution. Core Chapters Chapter 1: Research objectives, research methods, data sources, data cross-validation; Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 6: Detailed analysis of Phage Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc. Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc. Chapter 13: The main points and conclusions of the report. Frequently Asked Questions What factors will challenge the Product Name market growth? Which end-use segment will expand at the fastest CAGR in the Product Name market? Which are the emerging players in the Product Name market? How concentrated is the Product Name market? Which factors are positively contributing to the Product Name market growth? Which are the novel product innovations in the Product Name market? Which product segment will emerge as the most lucrative in the Product Name market? Which factors are increasing the competition in the Product Name market? Which are the strategic measures taken by the Product Name industry players? Which region will witness inactive growth during the forecast period? What key trends are likely to emerge in the Product Name market in the coming years?
1 Preface 1.1 Scope of Report 1.2 Reasons for Doing This Study 1.3 Research Methodology 1.4 Research Process 1.5 Data Source 1.5.1 Secondary Sources 1.5.2 Primary Sources 2 Market Overview 2.1 Product Definition 2.2 Phage Therapy by Type 2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029) 1.2.2 DsDNA Bacteriophage 1.2.3 SsDNA Bacteriophage 1.2.4 SsRNA Bacteriophage 1.2.5 Others 2.3 Phage Therapy by Application 2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) 2.3.2 Animal Health 2.3.3 Aquaculture 2.3.4 Agriculture 2.3.5 Food Industry 2.3.6 Human Health 2.3.7 Others 2.4 Assumptions and Limitations 3 Phage Therapy Breakdown Data by Type 3.1 Global Phage Therapy Historic Market Size by Type (2018-2023) 3.2 Global Phage Therapy Forecasted Market Size by Type (2023-2028) 4 Phage Therapy Breakdown Data by Application 4.1 Global Phage Therapy Historic Market Size by Application (2018-2023) 4.2 Global Phage Therapy Forecasted Market Size by Application (2018-2023) 5 Global Growth Trends 5.1 Global Phage Therapy Market Perspective (2018-2029) 5.2 Global Phage Therapy Growth Trends by Region 5.2.1 Global Phage Therapy Market Size by Region: 2018 VS 2022 VS 2029 5.2.2 Phage Therapy Historic Market Size by Region (2018-2023) 5.2.3 Phage Therapy Forecasted Market Size by Region (2024-2029) 5.3 Phage Therapy Market Dynamics 5.3.1 Phage Therapy Industry Trends 5.3.2 Phage Therapy Market Drivers 5.3.3 Phage Therapy Market Challenges 5.3.4 Phage Therapy Market Restraints 6 Market Competitive Landscape by Players 6.1 Global Top Phage Therapy Players by Revenue 6.1.1 Global Top Phage Therapy Players by Revenue (2018-2023) 6.1.2 Global Phage Therapy Revenue Market Share by Players (2018-2023) 6.2 Global Phage Therapy Industry Players Ranking, 2021 VS 2022 VS 2023 6.3 Global Key Players of Phage Therapy Head office and Area Served 6.4 Global Phage Therapy Players, Product Type & Application 6.5 Global Phage Therapy Players, Date of Enter into This Industry 6.6 Global Phage Therapy Market CR5 and HHI 6.7 Global Players Mergers & Acquisition 7 North America 7.1 North America Phage Therapy Market Size (2018-2029) 7.2 North America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 North America Phage Therapy Market Size by Country (2018-2023) 7.4 North America Phage Therapy Market Size by Country (2024-2029) 7.5 United States 7.6 Canada 8 Europe 8.1 Europe Phage Therapy Market Size (2018-2029) 8.2 Europe Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 8.3 Europe Phage Therapy Market Size by Country (2018-2023) 8.4 Europe Phage Therapy Market Size by Country (2024-2029) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 9 Asia-Pacific 9.1 Asia-Pacific Phage Therapy Market Size (2018-2029) 9.2 Asia-Pacific Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Asia-Pacific Phage Therapy Market Size by Country (2018-2023) 9.4 Asia-Pacific Phage Therapy Market Size by Country (2024-2029) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 10 Latin America 10.1 Latin America Phage Therapy Market Size (2018-2029) 10.2 Latin America Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Latin America Phage Therapy Market Size by Country (2018-2023) 10.4 Latin America Phage Therapy Market Size by Country (2024-2029) 9.4 Mexico 9.5 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Phage Therapy Market Size (2018-2029) 11.2 Middle East & Africa Phage Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029 11.3 Middle East & Africa Phage Therapy Market Size by Country (2018-2023) 11.4 Middle East & Africa Phage Therapy Market Size by Country (2024-2029) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 12 Players Profiled 11.1 NPO Microgen 11.1.1 NPO Microgen Company Detail 11.1.2 NPO Microgen Business Overview 11.1.3 NPO Microgen Phage Therapy Introduction 11.1.4 NPO Microgen Revenue in Phage Therapy Business (2017-2022) 11.1.5 NPO Microgen Recent Development 11.2 Proteon Pharmaceuticals 11.2.1 Proteon Pharmaceuticals Company Detail 11.2.2 Proteon Pharmaceuticals Business Overview 11.2.3 Proteon Pharmaceuticals Phage Therapy Introduction 11.2.4 Proteon Pharmaceuticals Revenue in Phage Therapy Business (2017-2022) 11.2.5 Proteon Pharmaceuticals Recent Development 11.3 Phagelux 11.3.1 Phagelux Company Detail 11.3.2 Phagelux Business Overview 11.3.3 Phagelux Phage Therapy Introduction 11.3.4 Phagelux Revenue in Phage Therapy Business (2017-2022) 11.3.5 Phagelux Recent Development 11.4 Intralytix 11.4.1 Intralytix Company Detail 11.4.2 Intralytix Business Overview 11.4.3 Intralytix Phage Therapy Introduction 11.4.4 Intralytix Revenue in Phage Therapy Business (2017-2022) 11.4.5 Intralytix Recent Development 11.5 Micreos 11.5.1 Micreos Company Detail 11.5.2 Micreos Business Overview 11.5.3 Micreos Phage Therapy Introduction 11.5.4 Micreos Revenue in Phage Therapy Business (2017-2022) 11.5.5 Micreos Recent Development 11.6 Eliava BioPreparations 11.6.1 Eliava BioPreparations Company Detail 11.6.2 Eliava BioPreparations Business Overview 11.6.3 Eliava BioPreparations Phage Therapy Introduction 11.6.4 Eliava BioPreparations Revenue in Phage Therapy Business (2017-2022) 11.6.5 Eliava BioPreparations Recent Development 11.7 Locus Biosciences,Inc 11.7.1 Locus Biosciences,Inc Company Detail 11.7.2 Locus Biosciences,Inc Business Overview 11.7.3 Locus Biosciences,Inc Phage Therapy Introduction 11.7.4 Locus Biosciences,Inc Revenue in Phage Therapy Business (2017-2022) 11.7.5 Locus Biosciences,Inc Recent Development 11.8 Pharmex Group,LLC 11.8.1 Pharmex Group,LLC Company Detail 11.8.2 Pharmex Group,LLC Business Overview 11.8.3 Pharmex Group,LLC Phage Therapy Introduction 11.8.4 Pharmex Group,LLC Revenue in Phage Therapy Business (2017-2022) 11.8.5 Pharmex Group,LLC Recent Development 11.9 Pherecydes Pharma 11.9.1 Pherecydes Pharma Company Detail 11.9.2 Pherecydes Pharma Business Overview 11.9.3 Pherecydes Pharma Phage Therapy Introduction 11.9.4 Pherecydes Pharma Revenue in Phage Therapy Business (2017-2022) 11.9.5 Pherecydes Pharma Recent Development 11.10 APS Biocontrol Ltd. (APS) 11.10.1 APS Biocontrol Ltd. (APS) Company Detail 11.10.2 APS Biocontrol Ltd. (APS) Business Overview 11.10.3 APS Biocontrol Ltd. (APS) Phage Therapy Introduction 11.10.4 APS Biocontrol Ltd. (APS) Revenue in Phage Therapy Business (2017-2022) 11.10.5 APS Biocontrol Ltd. (APS) Recent Development 11.11 Qingdao Phagepharm Bio-tech 11.11.1 Qingdao Phagepharm Bio-tech Company Detail 11.11.2 Qingdao Phagepharm Bio-tech Business Overview 11.11.3 Qingdao Phagepharm Bio-tech Phage Therapy Introduction 11.11.4 Qingdao Phagepharm Bio-tech Revenue in Phage Therapy Business (2017-2022) 11.11.5 Qingdao Phagepharm Bio-tech Recent Development 11.12 Fixed-Phage Limited 11.12.1 Fixed-Phage Limited Company Detail 11.12.2 Fixed-Phage Limited Business Overview 11.12.3 Fixed-Phage Limited Phage Therapy Introduction 11.12.4 Fixed-Phage Limited Revenue in Phage Therapy Business (2017-2022) 11.12.5 Fixed-Phage Limited Recent Development 11.13 Zeptometrix 11.13.1 Zeptometrix Company Detail 11.13.2 Zeptometrix Business Overview 11.13.3 Zeptometrix Phage Therapy Introduction 11.13.4 Zeptometrix Revenue in Phage Therapy Business (2017-2022) 11.13.5 Zeptometrix Recent Development 11.14 Phage International, Inc. 11.14.1 Phage International, Inc. Company Detail 11.14.2 Phage International, Inc. Business Overview 11.14.3 Phage International, Inc. Phage Therapy Introduction 11.14.4 Phage International, Inc. Revenue in Phage Therapy Business (2017-2022) 11.14.5 Phage International, Inc. Recent Development 11.15 MicroMir 11.15.1 MicroMir Company Detail 11.15.2 MicroMir Business Overview 11.15.3 MicroMir Phage Therapy Introduction 11.15.4 MicroMir Revenue in Phage Therapy Business (2017-2022) 11.15.5 MicroMir Recent Development 11.16 iNtODEWORLD, Inc. 11.16.1 iNtODEWORLD, Inc. Company Detail 11.16.2 iNtODEWORLD, Inc. Business Overview 11.16.3 iNtODEWORLD, Inc. Phage Therapy Introduction 11.16.4 iNtODEWORLD, Inc. Revenue in Phage Therapy Business (2017-2022) 11.16.5 iNtODEWORLD, Inc. Recent Development 11.17 NEXTBIOTICS 11.17.1 NEXTBIOTICS Company Detail 11.17.2 NEXTBIOTICS Business Overview 11.17.3 NEXTBIOTICS Phage Therapy Introduction 11.17.4 NEXTBIOTICS Revenue in Phage Therapy Business (2017-2022) 11.17.5 NEXTBIOTICS Recent Development 11.18 Armata Pharmaceuticals, Inc. 11.18.1 Armata Pharmaceuticals, Inc. Company Detail 11.18.2 Armata Pharmaceuticals, Inc. Business Overview 11.18.3 Armata Pharmaceuticals, Inc. Phage Therapy Introduction 11.18.4 Armata Pharmaceuticals, Inc. Revenue in Phage Therapy Business (2017-2022) 11.18.5 Armata Pharmaceuticals, Inc. Recent Development 11.19 Innophage 11.19.1 Innophage Company Detail 11.19.2 Innophage Business Overview 11.19.3 Innophage Phage Therapy Introduction 11.19.4 Innophage Revenue in Phage Therapy Business (2017-2022) 11.19.5 Innophage Recent Development 11.20 Adaptive Phage Therapeutics 11.20.1 Adaptive Phage Therapeutics Company Detail 11.20.2 Adaptive Phage Therapeutics Business Overview 11.20.3 Adaptive Phage Therapeutics Phage Therapy Introduction 11.20.4 Adaptive Phage Therapeutics Revenue in Phage Therapy Business (2017-2022) 11.20.5 Adaptive Phage Therapeutics Recent Development 11.21 TechnoPhage 11.21.1 TechnoPhage Company Detail 11.21.2 TechnoPhage Business Overview 11.21.3 TechnoPhage Phage Therapy Introduction 11.21.4 TechnoPhage Revenue in Phage Therapy Business (2017-2022) 11.21.5 TechnoPhage Recent Development 13 Report Conclusion 14 Disclaimer